Anti-VEGF/Ang-2 therapy shows fast drying in diabetic macular edema

LAS VEGAS — A VEGF/Ang-2 inhibitor demonstrated faster drying compared with faricimab in patients with diabetic macular edema, according to a study presented at Clinical Trials at the Summit. Margaret Chang, MD, MS, of Retinal Consultants Medical Group in Sacramento, California, presented results from the JADE proof-of-concept trial, which compared OLN324 (Ollin Biosciences) vs.